EX-10.33 36 d782664dex1033.htm EX-10.33 ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 AMENDMENT to the NON- EXCLUSIVE PATENT LICENSE...Non-Exclusive Patent License Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020
AMENDMENT to the NON-EXCLUSIVE PATENT LICENSE AGREEMENT dated 01 May 2014 (the “Amendment”)Non-Exclusive Patent License Agreement • June 28th, 2018 • BioNano Genomics, Inc • Laboratory analytical instruments
Contract Type FiledJune 28th, 2018 Company Industry